NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/25/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.18 mln
Float3.49 mln
Earnings Date08/13/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
21
/ 100
Significantly lagging
Debt / Equity
0.11
Very low leverage
ROE
-1,678
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Artelo Biosciences is a US-based clinical-stage drug development company focused on treatments that work through the body's lipid-signaling systems. Its pipeline includes three candidates targeting conditions such as cancer-related appetite loss, nerve pain, anxiety, depression, PTSD, and epilepsy. Founded in 2011 and headquartered in Solana Beach, California, the company operates under a name it adopted in 2017.
